Steven D. Wood - 15 Jul 2025 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Director
Signature
/s/ Steven D. Wood
Issuer symbol
MEIP
Transactions as of
15 Jul 2025
Net transactions value
$0
Form type
4
Filing time
17 Jul 2025, 21:40:54 UTC
Previous filing
21 May 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wood Steven D Director C/O MEI PHARMA, INC., 11455 EL CAMINO REAL, SUITE 250, SAN DIEGO /s/ Steven D. Wood 17 Jul 2025 0002001007

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MEIP Common Stock 4,359 15 Jul 2025 Direct
holding MEIP Common Stock 67,733 15 Jul 2025 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 15 Jul 2025 Common Stock 20,000 $3.07 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are held of record by GreenWood Builders Fund III, LP. Mr. Steven Wood is the Chief Investment Officer at GreenWood Investors LLC, who severs as investment advisor to GreenWood Builders Fund III, LP., and as such may be deemed to beneficially own the securities held by GreenWood Builders Fund III, LP. Mr Wood disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.
F2 Customary annual grant to non-employee directors of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025.